Bulletin
Investor Alert

London Markets Close in:

April 18, 2019, 8:20 a.m. EDT

Consolidated Research: 2019 Summary Expectations for Intec Pharma, Cerecor, Chiasma, Exela Technologies, PAVmed, and CUI Global -- Fundamental Analysis, Key Performance Indications

new
Watchlist Relevance
LEARN MORE

Want to see how this story relates to your watchlist?

Just add items to create a watchlist now:

  • X
    Intec Pharma Ltd. (NTEC)
  • X
    Cerecor Inc. (CERC)
  • X
    Chiasma Inc. (CHMA)

or Cancel Already have a watchlist? Log In

NEW YORK, April 18, Apr 18, 2019 (GLOBE NEWSWIRE via COMTEX) -- In new independent research reports released early this morning, Market Source Research released its latest key findings for all current investors, traders, and shareholders of Intec Pharma Ltd. /zigman2/quotes/204811863/composite NTEC -19.15% , Cerecor Inc. /zigman2/quotes/201368871/composite CERC +1.94% , Chiasma, Inc. /zigman2/quotes/207042362/composite CHMA +2.28% , Exela Technologies, Inc. /zigman2/quotes/207382046/composite XELA -0.26% , PAVmed Inc. /zigman2/quotes/203185294/composite PAVM +1.45% , and CUI Global, Inc. /zigman2/quotes/206557361/composite CUI +0.91% , including updated fundamental summaries, consolidated fiscal reporting, and fully-qualified certified analyst research.

Complimentary Access: Research Reports

Full copies of recently published reports are available to readers at the links below.

NTEC DOWNLOAD: http://MarketSourceResearch.com/register/?so=NTEC

CERC DOWNLOAD: http://MarketSourceResearch.com/register/?so=CERC

CHMA DOWNLOAD: http://MarketSourceResearch.com/register/?so=CHMA

XELA DOWNLOAD: http://MarketSourceResearch.com/register/?so=XELA

PAVM DOWNLOAD: http://MarketSourceResearch.com/register/?so=PAVM

CUI DOWNLOAD: http://MarketSourceResearch.com/register/?so=CUI

(You may have to copy and paste the link into your browser and hit the [ENTER] key)

The new research reports from Market Source Research, available for free download at the links above, examine Intec Pharma Ltd. /zigman2/quotes/204811863/composite NTEC -19.15% , Cerecor Inc. /zigman2/quotes/201368871/composite CERC +1.94% , Chiasma, Inc. /zigman2/quotes/207042362/composite CHMA +2.28% , Exela Technologies, Inc. /zigman2/quotes/207382046/composite XELA -0.26% , PAVmed Inc. /zigman2/quotes/203185294/composite PAVM +1.45% , and CUI Global, Inc. /zigman2/quotes/206557361/composite CUI +0.91% on a fundamental level and outlines the overall demand for their products and services in addition to an in-depth review of the business strategy, management discussion, and overall direction going forward. Several excerpts from the recently released reports are available to today's readers below.

-----------------------------------------

Important Notice: the following excerpts are not designed to be standalone summaries and as such, important information may be missing from these samples. Please download the entire research report, free of charge, to ensure you are reading all relevant material information. Percentage calculations are performed after rounding. All amounts in millions (MM), except per share amounts.

-----------------------------------------

INTEC PHARMA LTD. (NTEC) REPORT OVERVIEW

Intec Pharma's Recent Financial Performance

Analysts expect earnings to be released on May 21st, 2019. The report will be for the fiscal period ending March 31st, 2019. The reported EPS for the same quarter last year was -$0.41. The estimated EPS forecast for the next fiscal year is -$0.92 and is expected to report on February 26th, 2020.

To read the full Intec Pharma Ltd. (NTEC) report, download it here: http://MarketSourceResearch.com/register/?so=NTEC

-----------------------------------------

CERECOR INC. (CERC) REPORT OVERVIEW

Cerecor's Recent Financial Performance

For the three months ended December 31st, 2018 vs December 31st, 2017, Cerecor reported revenue of $4.98MM vs $2.23MM (up 123.15%) and analysts estimated basic earnings per share -$0.18 vs $0.23. For the twelve months ended December 31st, 2018 vs December 31st, 2017, Cerecor reported revenue of $18.33MM vs $27.81MM (down 34.11%) and analysts estimated basic earnings per share -$1.20 vs $0.42. Analysts expect earnings to be released on May 10th, 2019. The report will be for the fiscal period ending March 31st, 2019. Reported EPS for the same quarter last year was -$0.07. The estimated EPS forecast for the next fiscal year is -$0.72 and is expected to report on April 1st, 2019.

To read the full Cerecor Inc. (CERC) report, download it here: http://MarketSourceResearch.com/register/?so=CERC

-----------------------------------------

CHIASMA, INC. (CHMA) REPORT OVERVIEW

Chiasma's Recent Financial Performance

Analysts expect earnings to be released on May 9th, 2019. The report will be for the fiscal period ending March 31st, 2019. Reported EPS for the same quarter last year was -$0.29. The estimated EPS forecast for the next fiscal year is -$1.18 and is expected to report on March 13th, 2020.

To read the full Chiasma, Inc. (CHMA) report, download it here: http://MarketSourceResearch.com/register/?so=CHMA

/zigman2/quotes/204811863/composite
US : U.S.: Nasdaq
$ 0.53
-0.13 -19.15%
Volume: 827,586
Nov. 12, 2019 10:37a
P/E Ratio
N/A
Dividend Yield
N/A
Market Cap
$23.00 million
Rev. per Employee
N/A
loading...
/zigman2/quotes/201368871/composite
US : U.S.: Nasdaq
$ 3.42
+0.07 +1.94%
Volume: 14,310
Nov. 12, 2019 10:14a
P/E Ratio
N/A
Dividend Yield
N/A
Market Cap
$147.76 million
Rev. per Employee
$286,356
loading...
/zigman2/quotes/207042362/composite
US : U.S.: Nasdaq
$ 5.39
+0.12 +2.28%
Volume: 20,330
Nov. 12, 2019 10:36a
P/E Ratio
N/A
Dividend Yield
N/A
Market Cap
$221.42 million
Rev. per Employee
N/A
loading...
/zigman2/quotes/207382046/composite
US : U.S.: Nasdaq
$ 0.60
-0.0016 -0.26%
Volume: 40,336
Nov. 12, 2019 10:29a
P/E Ratio
N/A
Dividend Yield
N/A
Market Cap
$90.68 million
Rev. per Employee
$72,101
loading...
/zigman2/quotes/203185294/composite
US : U.S.: Nasdaq
$ 0.91
+0.01 +1.45%
Volume: 10,887
Nov. 12, 2019 10:21a
P/E Ratio
N/A
Dividend Yield
N/A
Market Cap
$33.49 million
Rev. per Employee
N/A
loading...
/zigman2/quotes/206557361/composite
US : U.S.: Nasdaq
$ 0.87
+0.0078 +0.91%
Volume: 13,624
Nov. 12, 2019 10:37a
P/E Ratio
N/A
Dividend Yield
N/A
Market Cap
$24.66 million
Rev. per Employee
$271,118
loading...
/zigman2/quotes/204811863/composite
US : U.S.: Nasdaq
$ 0.53
-0.13 -19.15%
Volume: 827,586
Nov. 12, 2019 10:37a
P/E Ratio
N/A
Dividend Yield
N/A
Market Cap
$23.00 million
Rev. per Employee
N/A
loading...
/zigman2/quotes/201368871/composite
US : U.S.: Nasdaq
$ 3.42
+0.07 +1.94%
Volume: 14,310
Nov. 12, 2019 10:14a
P/E Ratio
N/A
Dividend Yield
N/A
Market Cap
$147.76 million
Rev. per Employee
$286,356
loading...
/zigman2/quotes/207042362/composite
US : U.S.: Nasdaq
$ 5.39
+0.12 +2.28%
Volume: 20,330
Nov. 12, 2019 10:36a
P/E Ratio
N/A
Dividend Yield
N/A
Market Cap
$221.42 million
Rev. per Employee
N/A
loading...
/zigman2/quotes/207382046/composite
US : U.S.: Nasdaq
$ 0.60
-0.0016 -0.26%
Volume: 40,336
Nov. 12, 2019 10:29a
P/E Ratio
N/A
Dividend Yield
N/A
Market Cap
$90.68 million
Rev. per Employee
$72,101
loading...
/zigman2/quotes/203185294/composite
US : U.S.: Nasdaq
$ 0.91
+0.01 +1.45%
Volume: 10,887
Nov. 12, 2019 10:21a
P/E Ratio
N/A
Dividend Yield
N/A
Market Cap
$33.49 million
Rev. per Employee
N/A
loading...
/zigman2/quotes/206557361/composite
US : U.S.: Nasdaq
$ 0.87
+0.0078 +0.91%
Volume: 13,624
Nov. 12, 2019 10:37a
P/E Ratio
N/A
Dividend Yield
N/A
Market Cap
$24.66 million
Rev. per Employee
$271,118
loading...
1 2
This Story has 0 Comments
Be the first to comment

Story Conversation

Commenting FAQs »
Link to MarketWatch's Slice.